Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Experimental & Molecular MedicineOpen Access

Novel mechanism whereby metformin improves glucose homeostasis: TXNIP–GLUT1 axis modulation enhances intestinal glucotonic effects

View Full Paper
Ask AI
Bookmark
Share

Authors

CKChan Woo KangJNJung Ho NamJOJu Hun Oh

Discussion

Loading...

Member takes

Overview

Experimental analysis reveals metformin improves glucose uptake in intestinal cells, highlighting the TXNIP–GLUT1 relationship.

Key Points

  • Metformin enhances glucose excretion in the distal intestine, improving glucose homeostasis.
  • Inhibition of GLUT1 negated metformin's glucose-lowering effects, highlighting its critical role.
  • Experimental studies in mice and cell lines showed the regulatory TXNIP–GLUT1 axis is crucial for intestinal glucose metabolism.
  • Findings suggest novel therapeutic strategies targeting intestinal mechanisms for glucose regulation may be necessary.

Cite This Study

Kang et al. (2025) studied this question.

synapsesocial.com/papers/68c241efb210217d647a1291https://doi.org/10.1038/s12276-025-01518-w
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of the effects of metformin on gut functions and microbiota and their contribution to improving glucose tolerance in diabetic mice2025 · 7 citations
  2. 2Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycemic control2025 · 2 citations
  3. 3<b>From Metformin to Microbiome: The Missing Links in Metabolic Modulation</b>2025
  4. 4Metformin and Adipose Tissue: A Multifaceted Regulator in Metabolism, Inflammation, and Regeneration.2025
  5. 5Similarities and differences in the intestinal actions of metformin and imeglimin2025